More articles from e-Letters: Comments and Responses

Open Access
Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128–2136
Roselle A. Herring, Fariba Shojaee-Moradie, Robert Garesse, Mary Stevenage, Nicola Jackson, Barbara A. Fielding, Agampodi Mendis, Sigurd Johnsen, A. Margot Umpleby, Melanie Davies, David L. Russell-Jones

Diabetes Care Mar 2021, 44 (3) e61; DOI: 10.2337/dci20-0072
Open Access
Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128–2136
Geremia B. Bolli, Francesca Porcellati, Paola Lucidi, Carmine G. Fanelli

Diabetes Care Mar 2021, 44 (3) e59-e60; DOI: 10.2337/dc20-2575
Open Access
Comment on Zhou et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 2020;43:1593–1616
Thirunavukkarasu Sathish, Jonathan E. Shaw, Brian Oldenburg, Ajay Mahal

Diabetes Care Dec 2020, 43 (12) e204-e205; DOI: 10.2337/dc20-2124
Open Access
Response to Comment on Zhou et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 2020;43:1593–1616
Xilin Zhou, Ping Zhang

Diabetes Care Dec 2020, 43 (12) e206-e207; DOI: 10.2337/dci20-0063
Open Access
Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910–1919
Alice Larroumet, Ninon Foussard, Marie Monlun, Laurence Blanco, Kamel Mohammedi, Vincent Rigalleau

Diabetes Care Dec 2020, 43 (12) e198; DOI: 10.2337/dc20-1742
Open Access
Response to Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910–1919
Kevin M. Pantalone, Anita D. Misra-Hebert, Bartolome Burguera, Michael W. Kattan

Diabetes Care Dec 2020, 43 (12) e199; DOI: 10.2337/dci20-0061
Open Access
Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948–1957
Sushrima Gan, Adem Y. Dawed, Louise A. Donnelly, Anand T.N. Nair, Colin N.A. Palmer, Viswanathan Mohan, Ewan R. Pearson

Diabetes Care Dec 2020, 43 (12) e202-e203; DOI: 10.2337/dci20-0049
Open Access
Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948–1957
Awadhesh Kumar Singh, Ritu Singh, Kamlesh Khunti

Diabetes Care Dec 2020, 43 (12) e200-e201; DOI: 10.2337/dc20-1950
Open Access
Response to Comment on McIntyre and Moses The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic. Diabetes Care 2020;43:1433–1434
H. David McIntyre, Robert G. Moses

Diabetes Care Nov 2020, 43 (11) e193; DOI: 10.2337/dci20-0043
Open Access
Response to Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948–955
Soie Kwon, Clara Tammy Kim, Jung Pyo Lee

Diabetes Care Nov 2020, 43 (11) e191; DOI: 10.2337/dci20-0040

Pages